• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Episode 13 - Treatment Challenges for Progressive Disease

Video

Because there aren’t treatment options available for the management of progressive multiple sclerosis (MS), Patricia K. Coyle, MD, explains the challenges clinicians are faced with when treating patients who transition into a progressive stage of the disease.

Dr Coyle and Leslie Fish, PharmD, explain that although the topic of when to end therapy for patients who transition into a worsening stage is controversial, it is necessary to make personalized treatment decisions.

Dr Fish further explains how the rising costs of agents for the treatment MS further complicate management of MS and affect a clinician’s decision about when to begin or end therapy for a patient.


Related Videos
John Barkett, MBA
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Tom Belmont
Dr Mingyang Song
John Michael O'Brien, PharmD, MPH
Lalan Wilfong, MD
Katherine Baker, MD, MMHC
Dr Kimlin Tam Ashing
Nini Wu, MD, MBA
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.